| scholarly article | Q13442814 |
| P2093 | author name string | Neil A Bradbury | |
| Robert J Bridges | |||
| Kalpit Shah | |||
| Ying Jai | |||
| P2860 | cites work | Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1 | Q22001533 |
| Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases | Q24608197 | ||
| Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 | Q24644303 | ||
| Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening | Q28217255 | ||
| Aggresomes: a cellular response to misfolded proteins | Q28292275 | ||
| Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability | Q28535395 | ||
| Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plants | Q28537590 | ||
| Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation | Q30449378 | ||
| Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation | Q31393490 | ||
| A cystic fibrosis pancreatic adenocarcinoma cell line | Q33598519 | ||
| Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein | Q33636276 | ||
| Activation of the CFTR Cl- channel by trimethoxyflavone in vitro and in vivo | Q33646466 | ||
| Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator | Q33865171 | ||
| Relative expression of the human epithelial Na+ channel subunits in normal and cystic fibrosis airways | Q72005770 | ||
| The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful | Q77584639 | ||
| c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells | Q34094432 | ||
| Identification and validation of hits from high throughput screens for CFTR modulators | Q34121837 | ||
| Absorption of three wine-related polyphenols in three different matrices by healthy subjects | Q34173356 | ||
| High absorption but very low bioavailability of oral resveratrol in humans | Q34343815 | ||
| Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors | Q34532897 | ||
| Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis | Q34748891 | ||
| Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium | Q35000352 | ||
| Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1. | Q35036202 | ||
| Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice. | Q36063078 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Proteasome protease mediated regulation of cytokine induction and inflammation | Q36301130 | ||
| Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator. | Q36510038 | ||
| Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents | Q37121365 | ||
| Do you know the sex of your cells? | Q37575237 | ||
| Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds | Q37630776 | ||
| Bioavailability of resveratrol | Q37831925 | ||
| Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation. | Q38288759 | ||
| Potentiation of mutant CFTR Cl- channel currents by the naturally occurring stilbene compound resveratrol | Q39038142 | ||
| Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression | Q39202824 | ||
| Crosstalk between apoptosis and autophagy within the Beclin 1 interactome | Q39352440 | ||
| BH3 mimetics activate multiple pro-autophagic pathways | Q39565305 | ||
| ΔF508 CFTR surface stability is regulated by DAB2 and CHIP-mediated ubiquitination in post-endocytic compartments | Q39703906 | ||
| Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules | Q40323738 | ||
| The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro | Q40390182 | ||
| Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. | Q40530907 | ||
| Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects | Q40563465 | ||
| A mutation in the cystic fibrosis transmembrane conductance regulator generates a novel internalization sequence and enhances endocytic rates | Q40677468 | ||
| Characterization of PKA isoforms and kinase-dependent activation of chloride secretion in T84 cells. | Q41020023 | ||
| Peripheral protein quality control removes unfolded CFTR from the plasma membrane | Q41111670 | ||
| T84 cells: anion selectivity demonstrates expression of Cl- conductance affected in cystic fibrosis | Q41637792 | ||
| Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1. | Q41837091 | ||
| An improved method to obtain highly differentiated monolayers of human bronchial epithelial cells | Q42458062 | ||
| Isoproterenol-induced desensitization of mucin release in isolated rat submandibular acini | Q42489240 | ||
| Synonymous codon usage affects the expression of wild type and F508del CFTR. | Q42558062 | ||
| Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive | Q42816994 | ||
| Trans-resveratrol oral administration does not affect the enzymatic activities in rat small intestine | Q44131935 | ||
| Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. | Q44456385 | ||
| Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating. | Q44495355 | ||
| Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells | Q45879921 | ||
| Biosynthesis and degradation of CFTR. | Q45968383 | ||
| Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma | Q46137754 | ||
| Role of CFTR in airway disease | Q47606626 | ||
| VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface. | Q50670824 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2377-2384 | |
| P577 | publication date | 2015-09-02 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR. | |
| P478 | volume | 1850 |
| Q57474833 | Calcium-induced chloride secretion is decreased by Resveratrol in ileal porcine tissue |
| Q28073063 | Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives |
| Q36790589 | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
Search more.